Literature DB >> 6104975

Pharmacology of centrally acting hypotensive drugs.

P A van Zwieten.   

Abstract

1. A survey is given of the various aspects of centrally acting hypotensive drugs. The majority of centrally acting hypotensive agents act by way of central alpha-adrenoceptors, probably located in the pontomedullary region of the brain. These central receptors are stimulated by clonidine, guanfacine and various related compounds, and also by alpha-methylnoradrenaline, generated in vivo upon biotransformation of alpha-methyldopa within the brain. The stimulation of the alpha-adrenoceptors induces a decrease in peripheral sympathetic tone and thus a fall in arterial blood pressure and bradycardia. 2. The possibility that presynaptic alpha-adrenoceptors in the brain are involved in the central hypotensive action of clonidine, guanfacine and related compounds is discussed. Also, the possible involvement of central histaminergic and cholinergic receptors in central hypotensive effects is reviewed. 3. Various experimental compounds with a central hypotensive effect different from that of clonidine and related drugs are mentioned. 4. Finally, it is pointed out that the hypotensive effects of various beta-sympatholytic drugs and of prazosin are probably not of central origin.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6104975      PMCID: PMC1430104          DOI: 10.1111/j.1365-2125.1980.tb04899.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  49 in total

1.  Involvement of alpha-receptors in clonidine-induced inhibition of transmitter release from central monoamine neurones.

Authors:  K Starke; H Montel
Journal:  Neuropharmacology       Date:  1973-11       Impact factor: 5.250

2.  Evidence for a central activation of a vagal cardiodepressor reflex by clonidine.

Authors:  W Kobinger; A Walland
Journal:  Eur J Pharmacol       Date:  1972-08       Impact factor: 4.432

3.  Alpha sympathomimetic inhibition of adrenergic and cholinergic transmission in the rabbit heart.

Authors:  K Starke
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1972       Impact factor: 3.000

4.  Clonidine-induced cardiovascular effects after stereotaxic application in the hypothalamus of rats.

Authors:  H A Boudier; J M van Rossum
Journal:  J Pharm Pharmacol       Date:  1972-05       Impact factor: 3.765

5.  The interference of tricyclic antidepressants with the central hypotensive effect of clonidine.

Authors:  H W van Spanning; P A van Zwieten
Journal:  Eur J Pharmacol       Date:  1973-12       Impact factor: 4.432

6.  Desmethylimipramine and the hypotensive action of clonidine in the rabbit.

Authors:  R H Briant; J L Reid
Journal:  Br J Pharmacol       Date:  1972-11       Impact factor: 8.739

Review 7.  The central action of antihypertensive drugs, mediated via central alpha-receptors.

Authors:  P A van Zwieten
Journal:  J Pharm Pharmacol       Date:  1973-02       Impact factor: 3.765

8.  Modulating effect of central adrenergic neurones on a vagally mediated cardioinhibitory reflex.

Authors:  W Kobinger; A Walland
Journal:  Eur J Pharmacol       Date:  1973-06       Impact factor: 4.432

9.  Evidence for direct alpha-adrenoceptor stimulation of effector neurons in cardiovascular centers by clonidine.

Authors:  W Kobinger; L Pichler
Journal:  Eur J Pharmacol       Date:  1974-06       Impact factor: 4.432

10.  Central noradrenergic neurones and the cardiovascular actions of clonidine in the rabbit.

Authors:  C T Dollery; J L Reid
Journal:  Br J Pharmacol       Date:  1973-02       Impact factor: 8.739

View more
  9 in total

1.  Unintentional pediatric ophthalmic tetrahydrozoline ingestion: case files of the medical toxicology fellowship at the University of California, San Francisco.

Authors:  Suad A Al-Abri; He S Yang; Kent R Olson
Journal:  J Med Toxicol       Date:  2014-12

Review 2.  Drugs interacting with alpha adrenoceptors.

Authors:  P A van Zwieten
Journal:  Cardiovasc Drugs Ther       Date:  1989-04       Impact factor: 3.727

3.  Participation of cardiac presynaptic alpha 2-adrenoceptors in the bradycardiac effects of clonidine and analogues.

Authors:  A de Jonge; P B Timmermans; P A van Zwieten
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1981-08       Impact factor: 3.000

4.  Evidence supporting the existence of presynaptic alpha-adrenoceptors in the regulation of endogenous noradrenaline release upon hepatic sympathetic nerve stimulation in the dog liver in vivo.

Authors:  N Yamaguchi
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1982-12       Impact factor: 3.000

5.  Drug withdrawal and rebound hypertension: differential action of the central antihypertensive drugs moxonidine and clonidine.

Authors:  H Rupp; B Maisch; C G Brilla
Journal:  Cardiovasc Drugs Ther       Date:  1996-06       Impact factor: 3.727

6.  Involvement of central dopamine receptors in the hypotensive action of pergolide.

Authors:  A L Jadhav; R N Willett; H N Sapru; M F Lokhandwala
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1983-12       Impact factor: 3.000

Review 7.  Guanfacine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the treatment of hypertension.

Authors:  E M Sorkin; R C Heel
Journal:  Drugs       Date:  1986-04       Impact factor: 9.546

8.  α2 Adrenergic receptor-mediated inhibition of thermogenesis.

Authors:  Christopher J Madden; Domenico Tupone; Georgina Cano; Shaun F Morrison
Journal:  J Neurosci       Date:  2013-01-30       Impact factor: 6.167

9.  α 1-Adrenergic Receptor Blockade by Prazosin Synergistically Stabilizes Rat Peritoneal Mast Cells.

Authors:  Nozomu Abe; Hiroaki Toyama; Yutaka Ejima; Kazutomo Saito; Tsutomu Tamada; Masanori Yamauchi; Itsuro Kazama
Journal:  Biomed Res Int       Date:  2020-05-12       Impact factor: 3.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.